Humana AB (publ) (HUM.ST)

SEK 36.6

(3.39%)

Operating Expenses Summary of Humana AB (publ)

Humana AB (publ)'s latest annual operating expenses in 2023 was 376 Million SEK , down -80.96% from previous year.
Humana AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 2.45 Billion SEK , up 5.82% from previous quarter.
Humana AB (publ) reported a annual operating expenses of 8.7 Billion SEK in annual operating expenses 2022, up 14.17% from previous year.
Humana AB (publ) reported a annual operating expenses of 7.62 Billion SEK in annual operating expenses 2021, up 9.69% from previous year.
Humana AB (publ) reported a quarterly operating expenses of 2.47 Billion SEK for 2024 Q3, up 0.65% from previous quarter.
Humana AB (publ) reported a quarterly operating expenses of 2.32 Billion SEK for 2024 Q1, up 428.47% from previous quarter.

Annual Operating Expenses Chart of Humana AB (publ) (2023 - 2012)

Historical Annual Operating Expenses of Humana AB (publ) (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	376 Million SEK	-80.96%
2022	8.7 Billion SEK	14.17%
2021	7.62 Billion SEK	9.69%
2020	6.94 Billion SEK	4.14%
2019	6.67 Billion SEK	11.63%
2018	5.97 Billion SEK	1.79%
2017	5.87 Billion SEK	3.33%
2016	5.68 Billion SEK	7.63%
2015	5.28 Billion SEK	17.59%
2014	4.49 Billion SEK	42.49%
2013	3.15 Billion SEK	1153.02%
2012	251.47 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	2.45 Billion SEK	5.82%
2024 Q3	2.47 Billion SEK	0.65%
2024 Q1	2.32 Billion SEK	428.47%
2023 Q2	2.36 Billion SEK	0.81%
2023 Q1	2.34 Billion SEK	4.31%
2023 Q4	439 Million SEK	-80.45%
2023 FY	376 Million SEK	-95.68%
2023 Q3	2.24 Billion SEK	-5.19%
2022 Q3	2.2 Billion SEK	1.1%
2022 FY	8.7 Billion SEK	14.17%
2022 Q1	2.07 Billion SEK	5.77%
2022 Q2	2.17 Billion SEK	5.22%
2022 Q4	2.25 Billion SEK	2.27%
2021 Q2	1.95 Billion SEK	4.27%
2021 Q3	1.84 Billion SEK	-5.69%
2021 Q4	1.95 Billion SEK	6.3%
2021 FY	7.62 Billion SEK	9.69%
2021 Q1	1.87 Billion SEK	25.3%
2020 Q1	1.83 Billion SEK	29.52%
2020 Q3	1.75 Billion SEK	-6.49%
2020 Q4	1.49 Billion SEK	-15.02%
2020 Q2	1.88 Billion SEK	2.51%
2020 FY	6.94 Billion SEK	4.14%
2019 Q3	1.75 Billion SEK	-6.51%
2019 Q2	1.87 Billion SEK	14.97%
2019 FY	6.67 Billion SEK	11.63%
2019 Q1	1.63 Billion SEK	28.85%
2019 Q4	1.41 Billion SEK	-19.18%
2018 Q1	1.56 Billion SEK	0.97%
2018 FY	5.97 Billion SEK	1.79%
2018 Q4	1.26 Billion SEK	-17.16%
2018 Q3	1.52 Billion SEK	-5.68%
2018 Q2	1.61 Billion SEK	3.45%
2017 Q1	1.58 Billion SEK	-1.55%
2017 FY	5.87 Billion SEK	3.33%
2017 Q4	1.55 Billion SEK	3.06%
2017 Q3	1.5 Billion SEK	-6.23%
2017 Q2	1.6 Billion SEK	1.33%
2016 Q4	1.6 Billion SEK	6.0%
2016 FY	5.68 Billion SEK	7.63%
2016 Q2	1.47 Billion SEK	3.29%
2016 Q1	1.43 Billion SEK	3.62%
2016 Q3	1.51 Billion SEK	2.71%
2015 Q3	1.27 Billion SEK	-5.69%
2015 Q1	1.26 Billion SEK	0.0%
2015 Q2	1.35 Billion SEK	6.87%
2015 Q4	1.38 Billion SEK	8.07%
2015 FY	5.28 Billion SEK	17.59%
2014 FY	4.49 Billion SEK	42.49%
2013 FY	3.15 Billion SEK	1153.02%
2012 FY	251.47 Million SEK	0.0%

Peer Operating Expenses Comparison of Humana AB (publ)

Name	Operating Expenses	Operating Expenses Difference
Ambea AB (publ)	2.46 Billion SEK	84.715%
Attendo AB (publ)	4.64 Billion SEK	91.902%
ProstaLund AB (publ)	31.95 Million SEK	-1076.507%